New Zealand markets closed

aTyr Pharma, Inc. (LIFE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
8.53-0.04 (-0.47%)
At close: 4:00PM EDT
8.46 -0.07 (-0.82%)
After hours: 05:48PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close8.57
Open8.48
Bid8.40 x 800
Ask8.65 x 800
Day's range8.36 - 8.58
52-week range2.93 - 13.10
Volume425,426
Avg. volume5,353,020
Market cap236.29M
Beta (5Y monthly)1.61
PE ratio (TTM)N/A
EPS (TTM)-2.30
Earnings date10 Nov 2021 - 15 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est19.71
  • Zacks

    Do Options Traders Know Something About aTyr Pharma (LIFE) Stock We Don't?

    Investors need to pay close attention to aTyr Pharma (LIFE) stock based on the movements in the options market lately.

  • GlobeNewswire

    aTyr Pharma to Participate in Piper Sandler Investor Lung Day

    SAN DIEGO, Oct. 11, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer, will participate in a fireside chat as part of the Piper Sandler Virtual Investor Day: Developing Therapeutics for Lung Indications on Friday, October 15, 2021, at 9:00am ET / 6:00am PT. The discussion wi

  • GlobeNewswire

    aTyr Pharma Announces Appointment of Robert W. Ashworth, PhD, as Vice President of Regulatory Affairs

    SAN DIEGO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced the appointment of Robert W. Ashworth, Ph.D., to Vice President, Regulatory Affairs. Dr. Ashworth will serve as a member of the company’s executive leadership team, overseeing regulatory affairs functions and strategies. “aTyr is pleased to welcome Dr. Ashworth, an industry vet